Planet Green Holdings Corp. faces a critical existential threat characterized by a severe erosion of its revenue base, which plummeted from $2.2 million in 2023Q4 to $521.7K by 2025Q4. The company's financial stability is further compromised by a shift into ne...
Price trend, volume and key moving averages
Trailing total returns as of 10/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 14, 2026 | -$0.08 vs — | $790M vs — |
Q2 2026 May 15, 2026 | $0.04 vs — | $6M vs — |
Q2 2026 Mar 31, 2026 | -$1.46 vs — | $521,651 vs — |
Q4 2025 Nov 14, 2025 | -$0.47 vs — | $771,636 vs — |
NEW YORK, Oct. 20, 2026 /PRNewswire/ -- Planet Green Holdings Corp. ("Planet Green", the "Company") (NYSE American: PLAG) announced today that the Company had become aware of unusual trading activity in its common stock on the New York Stock Exchange American (the "NYSE") on October 19, 2026. The Company is issuing this press release pursuant to Section 401(d) of the NYSE Company Guide.
Planet Green Holdings Corp. (NYSEAMERICAN:PLAG - Get Free Report) saw a significant increase in short interest in July. As of July 31st, there was short interest totaling 95,717 shares, an increase of 128.1% from the July 15th total of 41,956 shares. Currently, 1.3% of the shares of the company are sold short. Based on an
Company Gains Access to Rare and Commercially Desirable High-Quality Lactoferrin for the Large and Rapidly Scaling Chinese Markets, Adding New Scientist to Drive New Product Development NEW YORK, Aug. 11, 2026 /PRNewswire/ -- Planet Green Holdings Corp. (NYSE American: PLAG) (the "Company"), operating a diversified portfolio of businesses, including consumer products and online advertising, today announced it has entered into commercial operations to source, market and distribute lactoferrin, a critical glycoprotein used in a wide range of health products, including the Company's chewable immune tablets. Lactoferrin is also widely used in infant formulas, sports nutrition, and a wide range of dietary and immune supplements.
Benchmark PLAG against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Planet Green Holdings Corp. (PLAG)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.42 | $5.91M | -0.12 | -54.82% | -887.18% | -566.49% | — | |
| $0.80 | $1.86M | — | 84.3% | -397.95% | -80.63% | — | |
| $0.94 | $27.87M | -3.60 | 15.17% | -3.05% | -15.02% | — | |
| $1.86 | $33.73M | 4.65 | 4.37% | 0.96% | — | — | |
| $2.55 | $462.16M | -3.92 | 340.86% | -48.58% | -171.75% | — | |
| $1.30 | $91.48M | -1.02 | -22.29% | -26.14% | — | — |
Planet Green Holdings Corp. (PLAG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Planet Green Holdings Corp. (PLAG) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 21, 2026·SEC
Aug 13, 2026·SEC
Jul 21, 2026·SEC
Get notified when PLAG posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Planet Green Holdings Corp. (PLAG) stock FAQ — growth, dividends, profitability & financials explained
Planet Green Holdings Corp. (PLAG) reported $8.4M in revenue for fiscal year 2025.
Planet Green Holdings Corp. (PLAG) saw revenue decline by 54.8% over the past year.
Planet Green Holdings Corp. (PLAG) reported a net loss of $26.0M for fiscal year 2025.
Planet Green Holdings Corp. (PLAG) has a return on equity (ROE) of -566.5%. Negative ROE indicates the company is unprofitable.
Planet Green Holdings Corp. (PLAG) generated $4.58B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
